The global antidiarrheal drugs market is anticipated to grow at a significant CAGR during the forecast period. The antidiarrheal drug is used to relieve the symptoms of diarrhea. Diarrhea is a non-serious condition that can be treated with over-the-counter medicines. The major factor for the growth of the global antidiarrheal market during the forecast period is the high prevalence of diarrhea cases. According to World Health Organization (WHO), diarrhea is the second leading cause of mortalities in children under five years old and was responsible for the mortalities of 370,000 children in 2019. Additionally, there are 1.7 billion cases of childhood diarrhea every year globally. Hence, the growing prevalence of diarrhea among children is driving the growth of the global antidiarrheal drugs market during the forecast period.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/antidiarrheal-drugs-market
Some key players in the market include Lupin Ltd., GlaxoSmithKline plc, and Pfizer, Inc., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in March 2021, Lupin launched the generic version of Alinia (nitazoxanide) tablets, 500 mg of Romark Laboratories. These tablets are used for the treatment of diarrhea caused by Giardia lamblia or Cryptosporidium parvum in patients of age 12 years and older.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
- Segment covered-
o By Type
o By Application
- Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
- Competitive Landscape-Lupin Ltd., GlaxoSmithKline plc, and Pfizer, Inc., among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Antidiarrheal Drugs Market Report by Segment
By Type
- OTC Drugs
- Prescription Drugs
By Application
- Children
- Adults
- Older People
A full report of Antidiarrheal Drugs Market is available at: https://www.omrglobal.com/industry-reports/antidiarrheal-drugs-market
Antidiarrheal Drugs Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Lupin Ltd.
- GlaxoSmithKline plc
- Pfizer, Inc.
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
